Studies on the epidemiology of hepatitis B and C virus infections are still needed

Journal of Hepatology

Volumn 62, Issue 6, 2015, Pages 1225-1227

  Deltenre, Pierre ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; EDITORIAL; EPIDEMIC; HEALTH CARE POLICY; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER CIRRHOSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SCREENING; BLOOD; FEMALE; MALE;

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ALANINE TRANSAMINASE; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE;

EID: 84929605751     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.02.044     Document Type: Editorial

References (17)

1. EASL clinical practice guidelines: management of chronic hepatitis B virus infection J Hepatol 57 2012 167 185
2. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J. Hutin, and B.P. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529 538
3. WHO, Hepatitis C, Fact sheet N°164, Updated April 2014. Available from < http://www.who.int/mediacentre/factsheets/fs164/en/ >.
4. S. Deuffic-Burban, P. Deltenre, M. Buti, T. Stroffolini, J. Parkes, and N. Muhlberger Predicted effects of treatment for HCV infection vary among European countries Gastroenterology 143 2012 974 985 e14
5. N. Muhlberger, R. Schwarzer, B. Lettmeier, G. Sroczynski, S. Zeuzem, and U. Siebert HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality BMC Public Health 9 2009 34
6. W.R. Kim Epidemiology of hepatitis B in the United States Hepatology 49 2009 S28 S34
7. J.J. Ott, G.A. Stevens, J. Groeger, and S.T. Wiersma Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 30 2012 2212 2219
8. K.N. Ly, J. Xing, R.M. Klevens, R.B. Jiles, J.W. Ward, and S.D. Holmberg The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 2012 271 278
9. G.L. Davis, M.J. Alter, H. El-Serag, T. Poynard, and L.W. Jennings Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression Gastroenterology 138 2010 513 521 521 e1-6
10. E. Gane, D. Kershenobich, C. Seguin-Devaux, P. Kristian, I. Aho, and O. Dalgard Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2 J Viral Hepat 22 2015 46 73
11. H. Wedemeyer, A.S. Duberg, M. Buti, W.M. Rosenberg, S. Frankova, and G. Esmat Strategies to manage hepatitis C virus (HCV) disease burden J Viral Hepat 21 2014 60 89
12. R. Fretz, F. Negro, P. Bruggmann, D. Lavanchy, A. De Gottardi, and I. Pache Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection Swiss Med Wkly 143 2013 w13793
13. A.S. Lok, and B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
14. B.D. Smith, R.L. Morgan, G.A. Beckett, Y. Falck-Ytter, D. Holtzman, and C.G. Teo Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 MMWR Recomm Rep 61 2012 1 32
15. B.D. Smith, R.L. Morgan, G.A. Beckett, Y. Falck-Ytter, D. Holtzman, and J.W. Ward Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention Ann Intern Med 157 2012 817 822
16. B. De Vroey, C. Moreno, W. Laleman, M. van Gossum, I. Colle, and C. de Galocsy Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management Eur J Gastroenterol Hepatol 25 2013 613 619
17. Wolffram I, Petroff D, Bätz O, Jedrysiak K, Kramer J, Tenckhoff H, et al. for the German "Check-Up 35+" Study Group, Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios. J Hepatol 2015;62:1256-1264.